Key result
Fetal permanent junctional reciprocating tachycardia was refractory to multiple prenatal antiarrhythmic therapies but was successfully treated postnatally with a combination of amiodarone, digoxin, and propranolol.
Why the study?
PJRT is a rare form of AVRT that is often refractory to antiarrhythmic therapy and difficult to distinguish from other types of fetal SVT in utero.
Case Report (n=1)
No
This case highlights that fetal permanent junctional reciprocating tachycardia can be highly refractory to multiple in utero antiarrhythmic therapies, necessitating a multidisciplinary approach and potentially early delivery.
Postnatal multidrug therapy may control refractory fetal PJRT; hypothesis-generating and should not change practice without further data.
Permanent junctional reciprocating tachycardia (PJRT) is a rare form of atrioventricular reentrant tachycardia that is commonly resistant to most antiarrhythmic medication therapy and over an extended duration can result in tachycardia-induced cardiomyopathy. The prenatal presentation of PJRT is typically similar to that of other types of fetal supraventricular tachycardia (SVT), making it difficult to distinguish from other forms of SVT in utero by fetal echocardiography. Surface electrocardiography after delivery is typically required to make a definitive diagnosis of PJRT. We report a case of fetal SVT at 19 weeks' gestation refractory to maternal transplacental treatment with digoxin, amiodarone, flecainide, sotalol, metoprolol, intraumbilical amiodarone, and fetal intramuscular digoxin over the course of 12 weeks. Repeat cesarean delivery was performed at 30 2/7 weeks' gestation for tachycardia-induced cardiomyopathy with hydrops fetalis. Postnatal electrocardiogram and continuous rhythm monitoring confirmed the diagnosis of PJRT. Combined neonatal treatment with amiodarone, digoxin, and propranolol was successful in reestablishment of sinus rhythm, with radiofrequency ablation planned if medical therapy eventually fails or once early childhood is reached. To our knowledge, this is the first described case of fetal PJRT refractory to multiple standard in utero antiarrhythmic modalities and highlights the importance of inclusion in the differential diagnosis.
No takes yet. Share an insight, caveat, or question.
Narang et al. (2020) conducted a case report in Fetal Permanent Junctional Reciprocating Tachycardia (n=1). Prenatal and postnatal antiarrhythmic therapy was evaluated on Resolution of tachycardia. Fetal permanent junctional reciprocating tachycardia was refractory to multiple prenatal antiarrhythmic therapies but was successfully treated postnatally with a combination of amiodarone, digoxin, and propranolol.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: